Blood Collection Market: Increasing Disease incidence and Growing number of Accidents and Trauma Cases

Pune, India, 2020-Aug-12 — /EPR Network/ — Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products.

Increasing disease incidence and growing number of accidents & trauma cases

The prevalence of infectious diseases such as Human Papillomavirus (HPV), hepatitis, Human Immunodeficiency Virus (HIV), and tuberculosis are high despite significant improvements in sanitation and medicine. Traditionally, antimicrobial therapy was used as a powerful tool to combat infectious diseases; however, over the years, antimicrobial agents have failed to deliver the desired results due to the emergence of drug-resistant microbes. Owing to this, the prevalence of these infectious diseases is increasing globally. The prevalence of lifestyle diseases is also growing across the globe. This will be favorable for the market growth, as blood tests are a primary mode of diagnosing these diseases. An increase in the number of road accidents, fires, and sports injuries has led to the increased occurrence of trauma and injury cases.

According to a WHO Global Status Report on Road Safety, in 2013, road accidents were the eighth-leading cause of death worldwide. Current trends show that by 2030, road accidents will become the fifth-leading cause of death, globally. The National Trauma Institute has stated that trauma injuries accounted for 30% of life years lost (a measure to account for the age at which deaths occur) in the US in 2014.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117

Opportunity: Technological advancements in blood collection procedures and products

Collecting blood samples from patients with Difficult Venous Access (DVA) is challenging or sometimes impossible. In DVA patients, the traditionally used blood collection products are often unable to collect adequate samples, which can also lead to repeated attempts to collect blood. This increases the risk of anemia in patients and the risk of transmission of blood-borne pathogens to nurses and phlebotomists.

To overcome this issue, innovative hematology-tube designs have been introduced to support capillary-blood collection for reducing the risks of collection and processing errors in DVA patients. Beside this, a vein illumination and visualization technique—vein finder, a recent addition to safe blood collection procedures—is used to assist healthcare professionals in finding a good vein for venipuncture. The device illuminates the veins beneath the skin using ultrasound or infrared technology and facilitates easy vein access, thus reducing the need for repeated venipuncture.

Challenge: Lack of skilled professionals

The knowledge of phlebotomy, blood collection, and transfusion is vital for effectively carrying out blood collection, especially via advanced systems such as automated blood collection systems, operated by professionals. Given their importance, the lack of professionals will significantly affect the growth of the market. This includes phlebotomy nurses, physicians, and blood bank professionals.

The effective collection of blood components requires careful monitoring of procedures and settings; as a result, the lack of technically knowledgeable personnel is expected to limit the adoption of advanced blood collection technologies in the coming years.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39733117

Key Market Players

Becton, Dickinson and Company, Medtronic, Terumo Corporation, Haemonetics, Fresenius, Nipro Medical Corporation, F.L. Medical, Greiner Holding, Smiths Group, Grifols, Kawasumi Laboratories, Quest Diagnostics, Sarstedt, Retractable Technologies, Ab Medical.